Clinical Overview > Condition/ Syndrome
You are looking at 1 - 10 of 561 items
Search for other papers by Sarah Badawod in
Google Scholar
PubMed
Search for other papers by Barna De in
Google Scholar
PubMed
Division of Neurosurgery, Dalhousie University, Halifax, Nova Scotia, Canada
Search for other papers by David B Clarke in
Google Scholar
PubMed
Division of Neurosurgery, Dalhousie University, Halifax, Nova Scotia, Canada
Search for other papers by Syed Ali Imran in
Google Scholar
PubMed
Summary
ACTH-secreting pituitary adenomas causing Cushing’s disease (CD) typically present with weight gain, whereas weight loss and hypokalemia in endogenous Cushing’s patients are suggestive of ectopic ACTH production. We report a case of CD presenting with atypical features of marked weight loss and hypokalemia. A 75-year-old female was admitted to the hospital with a history of profound weight loss, associated with uncontrolled hypertension, hyperglycemia, severe proximal muscle weakness, and hypokalemia. Subsequent investigations, including 24-h urinary free cortisol, 48-h low-dose dexamethasone suppression test, MRI of the sella, and bilateral inferior petrosal sinus sampling, confirmed CD without any evidence of ectopic ACTH production. She became eucortisolemic with medical therapy of ketoconazole and cabergoline, subsequently regained her weight, and became normokalemic. This case illustrates that patients with CD may present with symptoms and biochemical findings that would otherwise suggest ectopic ACTH production.
Learning points
-
Patients with CD do not always present with classical clinical features and may present with symptoms and biochemical findings that would otherwise suggest ectopic ACTH production.
-
While most patients with CD typically lose weight after biochemical remission, some patients gain weight after the normalization of cortisol levels.
-
This case highlights the need to entertain a broad differential in patients presenting with hypokalemia and weight loss and the need to exclude hypercortisolemia.
Endocrinology and Metabolism Unit, ASL Pescara, Pescara, Italy
Search for other papers by Ines Bucci in
Google Scholar
PubMed
Search for other papers by Cesidio Giuliani in
Google Scholar
PubMed
Search for other papers by Giulia Di Dalmazi in
Google Scholar
PubMed
Search for other papers by Daniele Intraina in
Google Scholar
PubMed
Search for other papers by Donato Zotta in
Google Scholar
PubMed
Search for other papers by Alfio Ieraci in
Google Scholar
PubMed
Search for other papers by Livio Presutti in
Google Scholar
PubMed
Endocrinology and Metabolism Unit, ASL Pescara, Pescara, Italy
Search for other papers by Giorgio Napolitano in
Google Scholar
PubMed
Summary
Brain metastases as the first clinical presentation of a papillary thyroid carcinoma (PTC) are exceptional, while cavernous angiomas are common cerebral malformations. We report the case of a 36-year-old male with an incidental brain lesion mimicking a cavernous angioma on MRI. Gamma knife radiosurgery was performed, but after 6 months, the patient developed neurological symptoms, and a repeat brain MRI revealed a significant increase in the mass. The patient underwent neurosurgery, and the histological examination of the lesion revealed metastatic carcinoma of thyroid origin. PET–CT and neck ultrasound, subsequently performed, were concordant for the presence of a right lobe nodule and ipsilateral lymph nodes, both with ultrasound features suspicious of malignancy. Total thyroidectomy with central and right lateral neck dissection was performed, and histology confirmed an intrathyroidal multifocal PTC with lymph node metastases. Postoperative radioiodine was administered, and focal uptake within the thyroid bed, without distant metastases or brain remnants, was found on the post-therapeutic whole-body scan. At 2 years from diagnosis, the patient is in good health and undergoes clinical and imaging follow-up.
Learning points
-
Brain cavernous angiomas are common cerebral vascular malformations that are usually diagnosed by MRI.
-
Despite the high accuracy of MRI, the exam is not pathognomonic, and misdiagnosis cannot be excluded.
-
Brain metastases from PTC are very rare; however, they can mimic a cavernous angioma. Therefore, the differential diagnosis should always be considered.
Search for other papers by Edward Mignone in
Google Scholar
PubMed
Search for other papers by Kirsten Neal in
Google Scholar
PubMed
Summary
Multiple endocrine neoplasia type 1 (MEN1) requires a high level of suspicion, and late diagnosis can lead to dire outcomes. Genetic counselling is an important part of management, with a lack of evidence surrounding an optimal approach in Aboriginal Australian populations. Our case surrounds a remote-dwelling 48-year-old Aboriginal Australian female who was reviewed by an inpatient endocrine team in 2020 for persistent hypercalcaemia on a background of a parathyroidectomy in 2011 for primary hyperparathyroidism (PHPT), while she was admitted to a local hospital for acute chronic abdominal pain. Relevant medical history included multiple pulmonary embolisms/deep vein thrombosis, myocardial infarction, atrial fibrillation, chronic thromboembolic pulmonary hypertension, right heart failure, human T-lymphotropic virus 1, recurrent abdominal pain, and gastro-oesophageal reflux disorder. Gastroscopies from 2013 and 2015 demonstrated chronic gastritis with hundreds of gastric polyps. Subsequent laboratory studies, neuroendocrine tumour (NET) screening, and CT imaging demonstrated a recurrence of PHPT and a new diagnosis of Zollinger–Ellison syndrome. A 68-gallium-DOTATATE PET/CT was in keeping with metastatic NET. Pituitary studies were normal. Genetic testing confirmed a rare heterozygous variant of c.207dupC in exon 2 of the MEN1 gene. Treatment was symptom based due to terminal comorbidities. Genetic counselling was attempted; however, cultural and logistical barriers were identified and the family declined further testing. Unfortunately, she died in 2021 from multifactorial respiratory failure. This case highlights the need for better approaches to genetic counselling systems for remote Aboriginal Australians and emphasizes the importance of early recognition and the challenges faced in remote areas in making such rare diagnoses.
Learning points
-
Remote healthcare systems often lack access to adequate specialist care, resulting in delayed diagnosis of rare conditions and leading to morbidity and mortality.
-
Further research and work need to be done to provide culturally appropriate genetic counselling systems in remote Aboriginal Australians.
-
A high index of suspicion is required to diagnose MEN1.
-
Consider MEN1 in any patient diagnosed with primary hyperparathyroidism, with age <40, and/or with the presence of multiglandular disease or with the presence of Zollinger–Ellison syndrome.
-
MEN1 may be under-recognized in Aboriginal Australians.
Search for other papers by Rikako Nakajima in
Google Scholar
PubMed
Search for other papers by Daisuke Sato in
Google Scholar
PubMed
Search for other papers by Ichirota Togashi in
Google Scholar
PubMed
Search for other papers by Hiroto Idesawa in
Google Scholar
PubMed
Search for other papers by Jun Ito in
Google Scholar
PubMed
Search for other papers by Kei Ito in
Google Scholar
PubMed
Search for other papers by Masanao Fujii in
Google Scholar
PubMed
Search for other papers by Hiroaki Yagyu in
Google Scholar
PubMed
Summary
An 89-year-old woman presented with a 6-year history of occasional episodes of impaired consciousness that were relieved by ingestion of a snack. Three months before presenting to our hospital, she had been hospitalized in a local hospital with subdural hematoma caused by a head contusion, where previously unrecognized hypoglycemia was discovered. Fasting plasma glucose concentration was 37 mg/dL, with a relatively high serum level of insulin (34.9 µU/mL). Computed tomography showed a 14 mm hyperenhancing tumor in the tail of the pancreas and she was referred to our hospital for further investigation. A prolonged fasting test revealed the plasma glucose concentration reduced to 43 mg/dL (2.4 mmol/L) at 8 h after the last meal. Serum insulin, proinsulin, and C-peptide concentrations were 21.1 µU/mL, 16.9 pmol/L, and 2.72 ng/mL, respectively. Subsequent intravenous administration of 1 mg of glucagon increased the plasma glucose concentration to 76 mg/dL (4.2 mmol/L). Moreover, the insulin-to-C-peptide molar ratio was 0.14. These data indicated the presence of insulinoma. Interestingly, serum anti-insulin antibodies were elevated (21.1 U/mL), although she had no history of taking exogenous insulin injection, alpha lipoic acid, or sulfhydryl group-containing agents. Human leukocyte antigen (HLA) typing revealed HLA-DRB1*0407 and HLA-DRB1*1405 alleles. Treatment with diazoxide prevented hypoglycemia, but was discontinued due to weight gain and leg edema. Elevated serum anti-insulin antibodies persisted almost 1 year after the diagnosis of insulinoma. We present a rare case of insulinoma concomitant with serum anti-insulin antibodies.
Learning points
-
Insulinoma presenting with concomitant anti-insulin antibodies appears rare.
-
Insulin/C-peptide molar ratio and serum insulin concentration are useful for differentiating insulinoma and autoimmune syndrome.
-
Flash glucose monitoring systems appear suitable for evaluating treatment outcomes.
Search for other papers by Maria Leonor Guia Lopes in
Google Scholar
PubMed
Nova Medical School, Clinical Medicine, New University of Lisbon, Lisbon, Portugal
Search for other papers by José Pedro Cidade in
Google Scholar
PubMed
Search for other papers by Clara Cunha in
Google Scholar
PubMed
Search for other papers by Clotilde Limbert in
Google Scholar
PubMed
Search for other papers by João Sequeira Duarte in
Google Scholar
PubMed
Summary
Riedel’s thyroiditis is the rarest form of thyroiditis, occasionally resulting in rapid thyroid enlargement and potential tracheal obstruction. Here, we detail the case of an 81-year-old woman with a medical history including Hodgkin lymphoma, Hashimoto’s thyroiditis, and multinodular goiter. She presented to the emergency room with stridor, cervical swelling, and breathing difficulties for over 2 days. CT scans revealed substantial thyroid enlargement causing significant glottal and tracheal compression, to a minimum tracheal diameter of 7 mm. Due to the severity of the compressive symptoms, orotracheal intubation and mechanical ventilation were deemed necessary. Surprisingly, despite the initial suspicion of malignancy given the rapid growth in the elderly, subsequent cytological and histological evaluations indicated a benign form of invasive fibrous thyroiditis – Riedel’s thyroiditis. Although surgical intervention was advised, the patient declined and opted for endobronchial treatment with a prosthetic stent and subsequent treatment with systemic glucocorticoids. Following successful treatment, she was discharged within a week and resumed normal activities without respiratory distress. This case is noteworthy for its rapid benign mass growth, rare emergent presentation, and the patient’s advanced age.
Learning points
-
The rapid enlargement of the thyroid gland in elderly patients poses a diagnostic challenge, stemming from the higher occurrence of aggressive thyroid carcinomas.
-
Despite the clinical presentation, a comprehensive diagnostic workup, including fine-needle aspiration and core-needle biopsy, is crucial for accurately distinguishing between benign and malignant causes of thyroid nodule enlargement.
-
This case report illustrates diverse treatment options for Riedel’s thyroiditis, and the importance of individualized treatment plans based on the degree of airway obstruction, patient preferences, and response to initial interventions.
-
Clinicians should contemplate the inclusion of glucocorticoids in the therapeutic regimen for Riedel’s thyroiditis, particularly in cases where surgical intervention is not feasible or declined by the patient.
Department of Digestive and Extra-Digestive Surgery, Porto, Portugal
Search for other papers by Ana Munhoz in
Google Scholar
PubMed
Department of Digestive and Extra-Digestive Surgery, Porto, Portugal
Search for other papers by Cláudia Paiva in
Google Scholar
PubMed
Department of Digestive and Extra-Digestive Surgery, Porto, Portugal
Obesity Treatment Center - Unidade de Tratamento Cirúrgico de Obesidade (UTCO), Porto, Portugal
CAC ICBAS-CHP, Porto, Portugal
I3S, Glycobiology and Cancer Research, Porto, Portugal
Search for other papers by Isabel Mesquita in
Google Scholar
PubMed
Department of Digestive and Extra-Digestive Surgery, Porto, Portugal
Obesity Treatment Center - Unidade de Tratamento Cirúrgico de Obesidade (UTCO), Porto, Portugal
Search for other papers by Teresa Correia in
Google Scholar
PubMed
Department of Digestive and Extra-Digestive Surgery, Porto, Portugal
Obesity Treatment Center - Unidade de Tratamento Cirúrgico de Obesidade (UTCO), Porto, Portugal
Search for other papers by Mário Marcos in
Google Scholar
PubMed
Department of Digestive and Extra-Digestive Surgery, Porto, Portugal
Obesity Treatment Center - Unidade de Tratamento Cirúrgico de Obesidade (UTCO), Porto, Portugal
Search for other papers by Jorge Santos in
Google Scholar
PubMed
Department of Digestive and Extra-Digestive Surgery, Porto, Portugal
Obesity Treatment Center - Unidade de Tratamento Cirúrgico de Obesidade (UTCO), Porto, Portugal
CAC ICBAS-CHP, Porto, Portugal
Search for other papers by Paulo Soares in
Google Scholar
PubMed
Summary
Bariatric surgery is increasingly being accepted as a viable treatment for managing the growing obesity epidemic. Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed procedures. Perforated duodenal ulcer following RYGB is a rare condition with a low incidence. We report a case of a patient with a perforated duodenal ulcer post RYGB, and the surgical approach. A 66-year-old man with hypertension and a history of laparoscopic RYGB for class III obesity was admitted to the emergency department with severe epigastric pain radiating to the right side of his abdomen and right shoulder, associated with nausea and vomiting. Computed tomography (CT) showed intraperitoneal free fluid, a thickened wall of the duodenum and free air, duodenal perforation was suspected. The patient underwent exploratory laparoscopy that revealed a perforated duodenal ulcer that was closed with an absorbable barbed suture and omental patch. Perforated ulcers in excluded segments after RYGB are a rare entity with a challenging diagnosis, and clinicians should be aware of and have a low threshold for diagnostic laparoscopy.
Learning points
-
Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed procedures in bariatric surgery.
-
Perforated ulcers in excluded segments after RYGB are a rare entity with a challenging diagnosis.
-
The pathophysiology of this perforation is not clear, but several mechanisms have been proposed. Helicobacter pylori has been implicated.
-
Clinicians should be aware and have a low threshold for diagnostic laparoscopy for a patient who has acute abdominal pain after RYGB, despite negative diagnostic measures.
Search for other papers by Kemal Fariz Kalista in
Google Scholar
PubMed
Search for other papers by Hanum Citra Nur Rahma in
Google Scholar
PubMed
Search for other papers by Dicky Levenus Tahapary in
Google Scholar
PubMed
Search for other papers by Saut Horas Nababan in
Google Scholar
PubMed
Search for other papers by Chynthia Olivia Maurine Jasirwan in
Google Scholar
PubMed
Search for other papers by Juferdy Kurniawan in
Google Scholar
PubMed
Search for other papers by Cosmas Rinaldi Adithya Lesmana in
Google Scholar
PubMed
Search for other papers by Andri Sanityoso Sulaiman in
Google Scholar
PubMed
Search for other papers by Irsan Hasan in
Google Scholar
PubMed
Search for other papers by Rino Gani in
Google Scholar
PubMed
Summary
Hypoglycemia is one of the paraneoplastic syndrome manifestations that arise from primary and secondary liver cancer. Hypoglycemia usually presents in the late stage of the disease and indicates a poor prognosis. This case series displays the characteristics profile of patients with primary and secondary liver cancer who are presented with hypoglycemia in a tertiary referral hospital in Indonesia. The study included 41 liver cancer patients who were presented with hypoglycemia. Hepatocellular carcinoma was diagnosed in 51.2% of patients, metastatic liver disease in 14.6% of patients, and undiagnosed liver cancer in 34.1% of patients. The mean age was 47.7 years with male predominance (65.9%). Jaundice was found in 58.5% and hepatomegaly in 70.7% of patients. The mean (± S.D.) initial blood glucose was 42.15 ± 17.11 mg/dL and the Child–Pugh score was 9.93 ± 2.11. Based on imaging, tumor diameter was 12.6 ± 6.9 cm, multiple (61%), and involving both lobes (61%). Treatments for hypoglycemia included oral/enteral feeding, intravenous dextrose, and steroids. No treatment was given for the cancer because all patients were in an advanced stage. The treatment resulted in 41.5% blood glucose being controlled, 56.1% refractory, and 2.4% persistent. Mortality was 70.7% and in average occurred 5.76 ± 4.99 days after hypoglycemia. The mainstay of treatment in these cases is treating the tumor with cytoreduction. However, it was difficult to do cytoreduction because the tumor was already in an advanced stage. Beneficial supportive treatments for maintaining normal blood glucose are frequent meals, dextrose infusion, steroids, and glucagon.
Learning points
-
Hypoglycemia in liver cancer occurs due to the failure of the liver to fulfill body glucose demand because the liver parenchyma has been largely replaced by the tumor, in addition to the high production of insulin growth factor (IGF).
-
Hypoglycemia is often caused by islet cell and non-islet cell tumors, with a higher occurrence in non-islet cell tumors due to paraneoplastic syndrome and the high metabolic requirements of the tumor.
-
The mainstay of NICTH treatment is treating the tumor with cytoreduction. However, in an advanced stage, cytoreduction therapy is often challenging to conduct. Beneficial supportive treatments for controlling blood glucose are frequent meals, dextrose infusion, and the injection of steroids and glucagon.
-
Steroids play a beneficial role in the treatment of persistent hypoglycemia in hepatocellular carcinoma by stimulating gluconeogenesis and increasing lipolysis. Steroids also have roles in the inhibition of peripheral glucose intake, suppression of big IGF-2 production, and modulation of the GH–IGF axis.
Search for other papers by Maxim John Levy Barnett in
Google Scholar
PubMed
Search for other papers by Carlo Casipit in
Google Scholar
PubMed
Search for other papers by Sri Ram Teja Sathi in
Google Scholar
PubMed
Search for other papers by Ana Del Carmen Rivadeneira Rodriguez in
Google Scholar
PubMed
Summary
Thyroid storm is a clinical diagnosis characterized by life-threatening multisystemic organ involvement in the setting of uncontrolled hyperthyroidism. Current estimates suggest a mortality rate of up to 30%. Treatment often consists of the administration of thionamide medications, iodine solution(s), corticosteroids, and beta-blockers; in extreme circumstances, both plasmapheresis and thyroidectomy are subsequent therapeutic options. Thionamides are typically administered orally, with the intent of preventing further thyroid hormone synthesis; however, in the literature, there are instances whereby oral access cannot be obtained, and alternative routes of administration are required. We present a case of a patient who presented with a thyroid storm due to lack of adherence to methimazole. During admission, he was found to have significant abdominal pain and ultimately a duodenal perforation requiring strict nil-per-os (NPO) status, due to which he was unable to receive oral thionamides. Due to the lack of availability of intravenous formulations of thionamides in the United States, this patient was treated with an enema compound of propylthiouracil for a total of five per rectum (PR) doses. He would later develop hepatocellular injury, requiring discontinuation and eventual transition to oral methimazole. The literature pertaining to alternative-route thionamide administration is scant, and therefore this case report and literature review is written to provide an up-to-date review and further educate all levels of clinicians about this infrequent (but emergent) situation.
Learning points
-
Thyroid storm is a clinical diagnosis for which urgent recognition is required to prevent untoward mortality.
-
Treatment for thyroid storm requires prompt administration of thionamides, iodine, corticosteroids, and beta-blockers. In extreme circumstances, treatment considerations include plasmapheresis and thyroidectomy.
-
Infrequently, patients with a thyroid storm may not be able to tolerate oral medications, for which alternative routes of access are required.
-
Currently, available alternatives include intravenous methimazole (in Europe and Japan), as well as both enema and suppository preparations of propylthiouracil and methimazole.
Search for other papers by M Majumder in
Google Scholar
PubMed
Cancer Genetics Laboratory, Kolling Institute of Medical Research, New South Wales, Sydney, Australia
Faculty of Medicine and Health, University of Sydney, New South Wales, Sydney, Australia
Search for other papers by M L Gild in
Google Scholar
PubMed
Cancer Genetics Laboratory, Kolling Institute of Medical Research, New South Wales, Sydney, Australia
Faculty of Medicine and Health, University of Sydney, New South Wales, Sydney, Australia
Search for other papers by B G Robinson in
Google Scholar
PubMed
Summary
Pregnancy in the setting of metastatic paraganglioma is challenging, particularly in the context of tyrosine kinase use. We describe a 26-year-old female with a background of metastatic paraganglioma harboring a pathogenic SDHB variant, requiring sunitinib, which was withheld to facilitate the safe conception and delivery of a healthy baby. She required no alpha- or beta-blockade during her pregnancy and exhibited no signs of tumor progression or symptoms throughout this period. Historically, higher rates of fetal and maternal morbidity and mortality have been experienced in the setting of pregnancy. Although limited data exist on the management of metastatic paraganglioma in pregnant patients, this case suggests that careful treatment modifications, such as temporary tyrosine kinase therapy cessation and vigilant monitoring, can result in successful pregnancies without compromising maternal or fetal well-being.
Learning points
-
Paraganglioma in pregnancy has been associated with poor fetal and maternal morbidity and mortality.
-
Many of the treatment modalities for metastatic paraganglioma, including tyrosine kinase inhibitors, can affect fertility or cannot be utilized in pregnancy, necessitating the temporary suspension of these treatments.
-
This case exemplifies that careful clinical and biochemical monitoring during pregnancy is required to avoid maternal and fetal harm while balancing the risk of disease progression off treatment.
Search for other papers by F Stringer in
Google Scholar
PubMed
Western Health, Melbourne, Victoria, Australia
Search for other papers by C Preston in
Google Scholar
PubMed
Australian Centre for Accelerating Diabetes Innovations, University of Melbourne, Victoria, Australia
Search for other papers by R MacIsaac in
Google Scholar
PubMed
Search for other papers by F Inchley in
Google Scholar
PubMed
Search for other papers by L Rivera-Woll in
Google Scholar
PubMed
Search for other papers by S Farrell in
Google Scholar
PubMed
Search for other papers by N Sachithanandan in
Google Scholar
PubMed
Summary
Congenital hyperinsulinism is the leading cause of persistent hypoglycaemia in infants and children; however, it is uncommon to be diagnosed in adulthood. We describe the cases of two sisters who presented with hyperinsulinaemic hypoglycaemia aged 47 and 57 years old, who were subsequently diagnosed with compound heterozygous likely pathogenic variants in the ABCC8 gene, a known cause of monogenic congenital hyperinsulinism. We discuss the typical presenting features, investigation findings, and treatment strategies for patients with this condition.
Learning Points
-
Congenital hyperinsulinism is a rare cause of hyperinsulinaemic hypoglycaemia diagnosed in adulthood.
-
Clinical presentation is similar to an insulinoma, and imaging modalities may assist in differentiation.
-
There are minimal medical therapies currently available for patients non-responsive to diazoxide (such as those with ABCC8 and KCNJ11 variants).
-
Continuous glucose monitoring can be helpful in giving patients autonomy in managing their disease, as well as relieving anxiety and fear associated with hypoglycaemia.
